Table 3 Long-term outcomes of adverse aortic-related events after TEVAR
Variables | All patients | Propensity-matched pairs | ||||
|---|---|---|---|---|---|---|
IMH group (n = 83) | AD group (n = 755) | P value | IMH group (n = 80) | AD group (n = 80) | P value | |
Aortic-related death | 6(7.2%) | 25(3.3%) | 0.137 | 6(7.5%) | 1(1.3%) | 0.117 |
Aortic rupture | 2(2.4%) | 12(1.6%) | 0.919 | 2(2.5%) | 2(2.5%) | 1.000 |
Dissection recurrence | 1(1.2%) | 20(2.6%) | 0.668 | 1(1.3%) | 1(1.3%) | 1.000 |
Stent endoleak | 0(0) | 21(2.8%) | 0.242 | 0(0) | 0(0) | NA |
Distal ulcer | 0(0) | 19(2.5%) | 0.283 | 0(0) | 0(0) | NA |
Stent thrombosis | 0(0) | 3(0.4%) | 1.000 | 0(0) | 0(0) | NA |
Retrograde tear | 0(0) | 8(1.1%) | 1.000 | 0(0) | 0(0) | NA |
Overall events | 9(10.8%) | 108(14.3%) | 0.388 | 9(11.3%) | 4(5.0%) | 0.148 |